Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals (Canada) Incorporated”

6 pharma patents match "Vertex Pharmaceuticals (Canada) Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "Vertex Pharmaceuticals (Canada) Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “Vertex Pharmaceuticals (Canada) Incorporated” · 30,257 patents in full index Clear search

  1. US 8829030

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  2. US 8357718

    Compounds and methods for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted
  3. US 8329924

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  4. US 8269014

    Thiophene analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  5. US 8158675

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted
  6. US 8003685

    Thiophene analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted